Nexovas Tablet

Introduction

Nexovas Tablet 5 mg is a calcium channel blocker used primarily in the treatment of hypertension (high blood pressure). It is a dihydropyridine derivative with specific properties that make it effective in managing blood pressure levels.

Uses

Nexovas Tablet 5 mg is used for:

Managing hypertension to help lower blood pressure and reduce the risk of cardiovascular complications.
It may be used in combination with other antihypertensive agents to achieve optimal blood pressure control.

Brand Name	Nexovas
Type	Tablet
Weight	5 mg
Generic	Cilnidipine
Manufacturer	Healthcare Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Nexovas Tablet 5 mg works by inhibiting the influx of calcium ions through L-type calcium channels in the vascular smooth muscle and cardiac tissue. This leads to relaxation of blood vessels, resulting in decreased peripheral resistance and lowered blood pressure.

How Long Does It Take to Work?

Clinical effects of Nexovas Tablet 5 mg can typically be observed within 1-2 hours of administration, with peak antihypertensive effects occurring within 4-6 hours. Full therapeutic effects are often seen after a few weeks of consistent use.

Absorption

Nexovas Tablet 5 mg is well absorbed from the gastrointestinal tract. Its bioavailability may be affected by food, with absorption potentially being reduced when taken with high-fat meals.

Route of Elimination

Nexovas Tablet 5 mg is metabolized primarily in the liver. It is excreted through the urine and bile, with a small portion eliminated unchanged in the urine.

Dosage

Adults: 5-10 mg once daily after breakfast. Maximum dose: 20 mg once daily.

Pediatric use: The safety of Cilnidipine in pediatric patients has not been established.

Elderly use: Since the elderly may be more susceptible to hypotension, therapy should be initiated with the lowest possible dose (5 mg).

The typical dosage of Nexovas Tablet 5 mg for hypertension is:

Adults: 10 mg to 20 mg once daily. The dosage may be adjusted based on the patient's response and tolerability.
Higher doses up to 40 mg daily may be prescribed for patients requiring more intensive blood pressure control.

Administration

Nexovas Tablet 5 mg is administered orally. It is typically taken once daily, with or without food. The tablets should be swallowed whole with a glass of water.

Side Effects

Common side effects of Nexovas Tablet 5 mg may include:

Headache
Dizziness
Flushing
Edema (swelling of the ankles or legs)

Less common but serious side effects may include:

Severe hypotension (low blood pressure)
Heart palpitations
Allergic reactions

Toxicity

Overdose of Nexovas Tablet 5 mg can result in severe hypotension, leading to symptoms such as dizziness, fainting, and rapid heart rate. In case of overdose, immediate medical attention is required to manage symptoms and provide supportive care.

Precautions

Precautions to consider include:

Monitoring blood pressure regularly to ensure it remains within the target range.
Using with caution in patients with liver impairment, as Nexovas Tablet 5 mg is metabolized by the liver.
Avoiding abrupt discontinuation to prevent rebound hypertension.

Interaction

Nexovas Tablet 5 mg may interact with other medications, potentially altering its efficacy or increasing the risk of side effects. Common interactions include:

Other antihypertensive agents, which may enhance the blood pressure-lowering effect.
Medications that affect liver enzymes, which can impact Nexovas Tablet 5 mg metabolism.

Disease Interaction

Use Nexovas Tablet 5 mg with caution in patients with:

Severe liver disease, as it may affect drug metabolism and clearance.
Heart failure or other cardiovascular conditions, as it may exacerbate these conditions in some cases.

Drug Interaction

Drug interactions to be aware of include:

Concomitant use with other calcium channel blockers or antihypertensive agents may enhance hypotensive effects.
Interactions with medications that alter CYP3A4 enzyme activity can affect Nexovas Tablet 5 mg levels.

Food Interactions

Food may affect the absorption of Nexovas Tablet 5 mg. It is generally advised to avoid high-fat meals around the time of taking the medication to prevent reduced absorption.

Pregnancy Use

The safety of Nexovas Tablet 5 mg during pregnancy has not been well-established. It should only be used if the potential benefits outweigh the risks, and under the guidance of a healthcare provider.

Lactation Use

It is not known whether Nexovas Tablet 5 mg is excreted in breast milk. Caution is advised when using this medication during lactation, and consultation with a healthcare provider is recommended.

Acute Overdose

In case of acute overdose, seek immediate medical attention. Treatment may include supportive measures and symptomatic management to address hypotension and other effects.

Contraindication

Nexovas Tablet 5 mg is contraindicated in individuals with:

Known hypersensitivity to Nexovas Tablet 5 mg or other dihydropyridine calcium channel blockers.
Severe liver impairment without appropriate dose adjustments.

Use Direction

Follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not alter the dose or frequency without medical advice.

Storage Conditions

Store Nexovas Tablet 5 mg tablets in a cool, dry place, away from direct sunlight. Keep them out of reach of children and ensure the container is tightly closed.

Volume of Distribution

The volume of distribution of Nexovas Tablet 5 mg is approximately 1.6 L/kg, indicating it is widely distributed throughout the body.

Half Life

The elimination half-life of Nexovas Tablet 5 mg is approximately 4 to 6 hours. This allows for once-daily dosing in most patients.

Clearance

Nexovas Tablet 5 mg is primarily cleared through hepatic metabolism and biliary excretion. Its clearance can be affected by liver function and concurrent use of other medications.

See in details version Nexovas Tablet 5 mg also Nexovas Tablet 5 mg in bangla